Stanford Cancer Center SC-2

Stanford, California 94305

We've found

1 trials

at this facility

A Study of the Anti-PD1 Antibody PDR001, in Combination With Dabrafenib and Trametinib in Advanced Melanoma

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Stanford, CA

Use our guide to learn which trials are right for you!